260 related articles for article (PubMed ID: 6257593)
21. Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo.
Krejs GJ; Barkley RM; Read NW; Fordtran JS
J Clin Invest; 1978 May; 61(5):1337-45. PubMed ID: 659596
[TBL] [Abstract][Full Text] [Related]
22. Effects of gastrointestinal hormones and carbamylcholine on cAMP accumulation in isolated pancreatic duct fragments from the rat.
Fölsch UR; Fischer H; Söling HD; Creutzfeldt W
Digestion; 1980; 20(4):277-92. PubMed ID: 6248407
[TBL] [Abstract][Full Text] [Related]
23. Distinct mechanisms for stimulation of intestinal secretion by vasoactive intestinal peptide (VIP) and glucagon.
Makhlouf GM
Gastroenterology; 1977 Feb; 72(2):368-9. PubMed ID: 830592
[No Abstract] [Full Text] [Related]
24. [Intestinal vasoactive peptide receptors in enterocytes : specific binding and stimulation of cyclic AMP].
Laburthe M; Besson J; Bon Hoa DH; Rosselin G
C R Acad Hebd Seances Acad Sci D; 1977 Jun; 284(21):2139-42. PubMed ID: 195749
[TBL] [Abstract][Full Text] [Related]
25. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
Lonovics J; Devitt P; Rayford PL; Thompson JC
Surg Forum; 1979; 30():407-9. PubMed ID: 538649
[No Abstract] [Full Text] [Related]
26. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
Gespach C; Hui Bon Hoa D; Rosselin G
Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture.
Laburthe M; Rousset M; Boissard C; Chevalier G; Zweibaum A; Rosselin G
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2772-5. PubMed ID: 208077
[TBL] [Abstract][Full Text] [Related]
28. Effect of vasoactive intestinal polypeptide on active and passive transport in the human jejunum.
Davis GR; Santa Ana CA; Morawski SG; Fordtran JS
J Clin Invest; 1981 Jun; 67(6):1687-94. PubMed ID: 6787081
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of intestinal secretion without reduction of cyclic AMP levels.
Lee MK; Coupar IM
Eur J Pharmacol; 1980 Dec; 68(4):501-3. PubMed ID: 6258936
[TBL] [Abstract][Full Text] [Related]
30. [cAMP concentration, cAMP metabolism and fluid secretion in the jejunum, ileum and colon of the rat caused by cholera toxin].
Loeschke K; Farack UM; Gerzer R; Keravis TM
Z Gastroenterol; 1986 Sep; 24 Suppl 3():57-61. PubMed ID: 3022492
[No Abstract] [Full Text] [Related]
31. Clostridium difficile toxin-induced intestinal secretion in rabbit ileum in vitro.
Hughes S; Warhurst G; Turnberg LA; Higgs NB; Giugliano LG; Drasar BS
Gut; 1983 Feb; 24(2):94-8. PubMed ID: 6303915
[TBL] [Abstract][Full Text] [Related]
32. Effect of VIP on sugar transport in rabbit small intestine in vitro.
Arruebo MP; Sorribas V; Rodriguez-Yoldi MJ; Murillo MD; Alcalde AI
Zentralbl Veterinarmed A; 1990 Mar; 37(2):123-9. PubMed ID: 2113749
[TBL] [Abstract][Full Text] [Related]
33. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit.
Hayashi K; Masuda K
Jpn J Ophthalmol; 1982; 26(4):437-42. PubMed ID: 6187959
[TBL] [Abstract][Full Text] [Related]
34. Neuropeptide Y inhibition of vasoactive intestinal polypeptide-stimulated ion transport in the rabbit distal colon.
Flint JS; Ballantyne GH; Goldenring JR; Fielding LP; Modlin IM
Arch Surg; 1990 Dec; 125(12):1561-3. PubMed ID: 2173897
[TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system.
Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141
[TBL] [Abstract][Full Text] [Related]
36. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.
Bataille D; Gespach C; Laburthe M; Amiranoff B; Tatemoto K; Vauclin N; Mutt V; Rosselin G
FEBS Lett; 1980 Jun; 114(2):240-2. PubMed ID: 6248367
[No Abstract] [Full Text] [Related]
37. Myoelectric effects of vasoactive intestinal peptide on rabbit small intestine.
Sninsky CA; Wolfe MM; Martin JL; Howe BA; O'Dorisio TM; McGuigan JE; Mathias JR
Am J Physiol; 1983 Jan; 244(1):G46-51. PubMed ID: 6849393
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II and norepinephrine antagonize the secretory effect of VIP in rat ileum and colon.
Bhaskar Rao M; O'Dorisio TM; Cataland S; George JM; Gaginella TS
Peptides; 1984; 5(2):291-4. PubMed ID: 6473156
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
Longshore MA; Makman MH
Eur J Pharmacol; 1981 Mar; 70(2):237-40. PubMed ID: 7262187
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal polypeptide promotes cyclic adenosine 3',5'-monophosphate accumulation in guinea-pig trachea.
Frandsen EK; Krishna GA; Said SI
Br J Pharmacol; 1978 Mar; 62(3):367-9. PubMed ID: 205290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
